News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SDIX (SDIX) Launches Apo B Antibody in IVD Market



7/21/2011 8:38:26 AM

NEWARK, Del.--(BUSINESS WIRE)--SDIX (NASDAQ: SDIX), a leading provider of In Vitro Diagnostic (IVD) reagents, today announced its plan to introduce a new polyclonal antisera to its product line for the IVD market. The product, Apo B, will be available as antisera and in fractionated forms.

Read at BioSpace.com


comments powered by Disqus
SDIX
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES